HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Jove Selected Research

Richard Jove Research Topics

Disease

85Neoplasms (Cancer)
11/2020 - 01/2000
17Melanoma (Melanoma, Malignant)
05/2016 - 10/2002
14Breast Neoplasms (Breast Cancer)
06/2018 - 01/2003
11Neoplasm Metastasis (Metastasis)
05/2018 - 01/2002
11Prostatic Neoplasms (Prostate Cancer)
02/2014 - 11/2002
11Carcinogenesis
12/2011 - 01/2002
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2012 - 10/2002
7Leukemia
05/2013 - 09/2002
6Ovarian Neoplasms (Ovarian Cancer)
09/2020 - 01/2011
5Carcinoma (Carcinomatosis)
03/2007 - 03/2004
3Glioblastoma (Glioblastoma Multiforme)
01/2014 - 03/2003
3Infections
07/2009 - 01/2000
3Adenocarcinoma
08/2008 - 11/2002
2Ascites
05/2018 - 12/2014
2Obesity
06/2015 - 08/2013
2Insulin Resistance
06/2015 - 08/2013
2Glioma (Gliomas)
09/2014 - 04/2010
2Osteosarcoma (Osteogenic Sarcoma)
11/2013 - 03/2007
2Inflammation (Inflammations)
08/2013 - 11/2009
2Neuroblastoma
07/2013 - 05/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2013 - 03/2006
2Medulloblastoma
04/2012 - 11/2008
2Multiple Myeloma
02/2009 - 01/2000
2Hematologic Neoplasms (Hematological Malignancy)
11/2008 - 09/2002
2Hypoxia (Hypoxemia)
07/2008 - 08/2005
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2008 - 04/2007
2Philadelphia Chromosome
05/2008 - 04/2007
2Small Cell Carcinoma
07/2006 - 07/2003
2Lung Neoplasms (Lung Cancer)
06/2006 - 07/2003
2Blast Crisis (Blast Phase)
08/2003 - 10/2002

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
11/2014 - 10/2002
18Phosphotransferases (Kinase)IBA
05/2015 - 03/2002
14STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2016 - 03/2002
14src-Family KinasesIBA
02/2014 - 10/2002
10Small Interfering RNA (siRNA)IBA
12/2014 - 03/2007
9Dasatinib (BMS 354825)FDA Link
09/2020 - 10/2005
9Interleukin-6 (Interleukin 6)IBA
04/2016 - 01/2000
9CytokinesIBA
12/2014 - 04/2002
7DNA (Deoxyribonucleic Acid)IBA
05/2012 - 07/2003
7Tyrosine (L-Tyrosine)FDA Link
08/2005 - 03/2002
6Janus KinasesIBA
11/2014 - 04/2002
6Cyclin D1IBA
11/2013 - 09/2005
5Transcription Factors (Transcription Factor)IBA
11/2014 - 01/2000
5SurvivinIBA
02/2014 - 01/2006
5ErbB Receptors (EGF Receptor)IBA
06/2006 - 04/2002
4MicroRNAs (MicroRNA)IBA
11/2020 - 12/2010
4Sorafenib (BAY 43-9006)FDA Link
05/2016 - 11/2008
4Messenger RNA (mRNA)IBA
05/2016 - 08/2003
4Histone Deacetylase InhibitorsIBA
06/2011 - 08/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2010 - 03/2002
4Imatinib Mesylate (Gleevec)FDA Link
04/2007 - 10/2002
3Paclitaxel (Taxol)FDA LinkGeneric
09/2020 - 06/2009
3Janus Kinase InhibitorsIBA
08/2019 - 06/2011
3Fatty Acids (Saturated Fatty Acids)IBA
06/2018 - 06/2015
3PlatinumIBA
05/2018 - 12/2004
3Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
04/2016 - 07/2013
3Biomarkers (Surrogate Marker)IBA
12/2014 - 01/2006
3berbamine (penduline)IBA
01/2014 - 10/2012
3InterleukinsIBA
07/2013 - 09/2002
3indirubinIBA
06/2013 - 04/2005
3Estrogen ReceptorsIBA
06/2013 - 01/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011 - 04/2002
3Epidermal Growth Factor (EGF)IBA
08/2008 - 03/2003
2Tyrosine Kinase InhibitorsIBA
09/2020 - 09/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2018 - 01/2006
2Formaldehyde (Formol)FDA Link
01/2017 - 01/2006
2ParaffinIBA
01/2017 - 01/2006
2Glucose (Dextrose)FDA LinkGeneric
06/2015 - 08/2013
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2014 - 09/2014
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2014 - 12/2010
2Caspase 3 (Caspase-3)IBA
11/2013 - 04/2005
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2013 - 01/2012
2Fibronectins (Fibronectin)IBA
12/2012 - 02/2009
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
05/2012 - 12/2010
2Proteasome InhibitorsIBA
04/2012 - 01/2000
2Apoptosis Regulatory ProteinsIBA
04/2012 - 11/2008
2Annexin A5IBA
01/2012 - 06/2011
2ChromatinIBA
12/2011 - 12/2008
2RNA (Ribonucleic Acid)IBA
12/2011 - 07/2008
2AZD 1480IBA
11/2011 - 12/2009
2NF-kappa B (NF-kB)IBA
11/2009 - 04/2009
2bosutinibIBA
06/2009 - 05/2008
2PhosphotyrosineIBA
06/2009 - 03/2003
2bcr-abl Fusion ProteinsIBA
12/2008 - 10/2002
2Mitogen-Activated Protein Kinase 3IBA
11/2008 - 03/2003
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
11/2008 - 11/2005
2AndrogensIBA
03/2007 - 07/2006
2Antisense OligonucleotidesIBA
01/2006 - 03/2002
2Hydroxamic Acids (Hydroxamic Acid)IBA
04/2005 - 08/2003
2Histone Deacetylases (Histone Deacetylase)IBA
04/2005 - 08/2003
2tanespimycin (17AAG)IBA
04/2005 - 10/2002
2PD 180970IBA
07/2003 - 10/2002
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2002 - 10/2002
2LigandsIBA
04/2002 - 01/2002
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2020
1Sunitinib (Sutent)FDA Link
09/2020

Therapy/Procedure

24Therapeutics
11/2020 - 01/2000
7Drug Therapy (Chemotherapy)
11/2020 - 12/2003
2Immunotherapy
01/2006 - 09/2003
1Palliative Care (Palliative Therapy)
11/2020